Novo Nordisk, the maker of the blockbuster obesity injection, has singlehandedly saved the country from a recession
In the leafy middle-class suburb of Bagsværd, near a lake north-west of Copenhagen, the drugmaker Novo Nordisk’s white circular headquarters rise from the ground like a giant flying saucer. The building looks like a sci-fi film set made by Lego, another stalwart of the Danish economy.
Thanks to booming demand for its weight loss treatment Wegovy, the Danish business last week became Europe’s biggest company by stock market value, overtaking the previous holder of that title, French luxury group LVMH. Novo Nordisk’s stock market value of £340bn now exceeds Denmark’s entire economic output, estimated at £323bn this year.
About Author
More Stories
TikTok fined €530m by Irish regulator for failing to guarantee China would not access user data
Tech giants beat quarterly expectations as Trump’s tariffs hit the sector
Renault and Citroën owner warn of ‘painful decisions’ if EU does not change rules for small cars